Home Data Calendar Blog

RCUS

Tables

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Common Stock Value 1582.001561.001311.001291.001267.001226.001206.000.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.00NANANANANA
Weighted Average Number Of Diluted Shares Outstanding 91.1086.20NA74.6073.2073.00NA72.2471.8071.20NA70.11NANA63.5365.1548.5644.28NA43.94NANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 91.1086.20NA74.6073.2073.00NA72.2471.8071.20NA70.11NANA63.5362.6050.1545.95NA45.7945.4144.53NA44.4544.4511.60NA3.99
Earnings Per Share Basic -1.02-0.05NANA-1.04-1.09-0.93-0.90NANA4.04-1.11NANA-0.870.03NANA-0.37-0.51NANANANANANANANA
Earnings Per Share Diluted -1.02-0.05NANA-1.04-1.09-0.93-0.90NANA3.99-1.11NANA-0.870.03NANA-0.37-0.51NANANANANANANANA
Income Loss From Continuing Operations Per Basic Share NANA-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00NANA-0.000.00-0.00-0.00-0.00-0.00NANANANANANANANA
Income Loss From Continuing Operations Per Diluted Share NANA-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00NANA-0.000.00-0.00-0.00-0.00-0.00NANANANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Revenue From Contract With Customer Excluding Assessed Tax 39.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Revenues 39.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Operating Expenses 145.00161.00122.00112.00112.00111.00108.10102.9895.7485.1973.2387.6085.6082.2161.5062.9847.1230.1527.2825.0030.9120.5215.0516.4417.1514.5814.5923.30
Research And Development Expense 115.00109.0093.0082.0084.0081.0080.2076.6869.9161.2149.9471.2568.7766.3948.7151.8035.6923.1420.6917.2425.0015.5511.4412.8613.7011.6512.1521.43
General And Administrative Expense 30.0032.0029.0030.0028.0030.0027.9026.2925.8423.9723.3016.3416.8315.8212.7911.1811.437.016.597.765.914.973.613.583.452.932.451.86
Operating Income Loss -106.00-16.00-91.00-80.00-83.00-86.00-74.44-69.40-68.98-67.18281.27-78.14-76.14-72.75-52.011.55-45.38-28.40-17.53-23.25-29.16-18.77-13.48-12.14-15.90-13.33-13.34-23.13
Allocated Share Based Compensation Expense 20.0020.0018.0018.0018.0019.0016.5216.2615.6816.5414.2914.5913.3712.768.076.004.473.46NA2.742.131.67NA1.051.120.66NA0.14
Income Tax Expense Benefit NANA1.002.001.002.00-0.000.000.001.00NANANANANANANANANANANANANANANANANANA
Profit Loss -93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21NA
Other Comprehensive Income Loss Net Of Tax NA-1.00NA1.00NA3.00NA-2.56-2.58-3.40NA-0.05-0.04-0.05NA-0.06-0.140.22NA-0.060.080.14NA-0.030.01-0.06NANA
Net Income Loss -93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21-23.12
Comprehensive Income Net Of Tax -93.00-5.00-78.00-70.00-75.00-77.00-64.92-67.48-69.22-71.39278.20-78.02-76.01-72.64-51.891.76-45.22-27.53-16.59-22.41-28.01-17.53-12.29-10.84-13.52-13.01-13.24-23.11

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Assets 1186.001293.001095.001191.001220.001254.001345.001393.821476.771543.431591.90839.29898.77935.12772.29811.08481.39176.14203.11216.96238.97258.53274.93286.72293.87305.40190.49NA
Liabilities And Stockholders Equity 1186.001293.001095.001191.001220.001254.001345.001393.821476.771543.431591.90839.29898.77935.12772.29811.08481.39176.14203.11216.96238.97258.53274.93286.72293.87305.40190.49NA
Stockholders Equity 635.00707.00462.00520.00566.00600.00657.00698.70747.39796.58841.45542.61604.55664.79502.30544.42428.71140.64163.84177.23196.65221.57234.94245.12254.57266.59-72.33NA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Assets Current 1022.001064.00831.00882.00986.001015.001067.001101.121227.471264.231261.75545.29745.95841.87735.82797.20471.60166.22192.71200.49227.73245.01258.95265.28267.44282.07176.87NA
Cash And Cash Equivalents At Carrying Value 156.00185.00127.00184.00230.00238.00206.00217.65272.63548.78147.91179.43320.48390.26173.41221.85285.1967.3357.9478.9976.0768.5071.0674.89170.00198.1298.4318.31
Prepaid Expense And Other Assets Current 25.0034.0034.0031.0022.0028.0019.0021.6215.6718.5315.6217.5721.978.685.4711.828.668.014.304.223.273.082.322.331.551.831.14NA
Available For Sale Securities Debt Securities 1009.001095.00866.00950.001010.001044.001138.001191.921271.111342.37681.30NANANA735.09NANANANANANANANANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Property Plant And Equipment Gross NANA82.00NANANA58.00NANANA50.18NANANA25.09NANANA20.5520.3819.8419.6218.7518.4618.2316.6215.21NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NANA31.00NANANA23.00NANANA17.73NANANA14.29NANANA11.2210.379.488.607.646.705.724.813.98NA
Property Plant And Equipment Net 49.0051.0051.0050.0045.0037.0035.0033.8933.4233.4832.4528.8223.8114.8510.818.738.268.769.3310.0110.3611.0311.1111.7612.5111.8111.23NA
Other Assets Noncurrent 75.0078.00106.00108.00109.00112.00114.0010.6010.5210.897.737.905.786.186.252.251.320.960.870.260.320.320.280.200.200.201.50NA
Available For Sale Debt Securities Amortized Cost Basis 1010.001096.00866.00953.001014.001048.001145.001201.721278.351347.03682.56NANANA735.04NANANANANANANANANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Liabilities Current 199.00204.00184.00200.00180.00179.00193.00177.18164.02161.25166.08142.87130.37132.06121.67162.8740.0221.0022.7121.0626.5119.0016.9316.6116.3814.2612.73NA
Accounts Payable Current 15.0016.0017.0017.0012.0028.0020.0010.5521.9818.0910.2613.2216.9624.5415.688.1012.052.434.702.902.452.833.102.115.393.923.82NA
Other Liabilities Current 71.0064.0076.0080.0065.0054.0076.002.982.47NA0.050.210.382.383.573.421.461.411.481.491.511.541.561.581.651.730.77NA
Contract With Customer Liability Current 113.00124.0091.00103.00103.0097.0097.00103.2990.1289.31102.0074.3474.5774.5774.57115.617.007.007.007.007.007.00NANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Other Liabilities Noncurrent 138.00140.00142.00145.00144.00145.00140.0016.1714.6813.875.2610.2010.2010.2010.258.180.690.640.811.031.281.541.792.052.312.550.56NA
Operating Lease Liability Noncurrent NANA110.00NANANA117.00119.19121.34114.81116.8948.9449.7414.7115.24NANANANANANANANANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Stockholders Equity 635.00707.00462.00520.00566.00600.00657.00698.70747.39796.58841.45542.61604.55664.79502.30544.42428.71140.64163.84177.23196.65221.57234.94245.12254.57266.59-72.33NA
Common Stock Value 1582.001561.001311.001291.001267.001226.001206.000.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.00NANANANANA
Retained Earnings Accumulated Deficit -946.00-853.00-849.00-768.00-697.00-622.00-542.00-474.90-409.98-343.35-275.35-554.72-476.75-400.78-328.18-276.33-278.15-233.08-205.33-188.73-166.38-138.29-122.83-110.53-99.72-86.19-73.23NA
Accumulated Other Comprehensive Income Loss Net Of Tax -1.00-1.00NA-3.00-4.00-4.00-7.00-9.80-7.24-4.66-1.26-0.09-0.05-0.000.040.080.140.290.060.050.110.03-0.11-0.11-0.08-0.10-0.04NA
Stock Issued During Period Value New Issues NA228.00NA5.0020.00NANANANANANANANANANANA326.25NANANANANANANANA124.72NANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 20.0020.00NA18.0018.0019.00NA16.2615.6816.54NA14.5913.3712.76NA6.004.473.46NA2.742.131.67NA1.051.120.66NANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Operating Activities -94.00-2.00-88.00-63.00-57.00-98.00-69.74-80.96-65.30654.00-62.10-53.76-74.00-66.32-49.88216.26-23.94-31.28-9.47-27.40-19.75-16.84-7.11-11.77-10.88-13.2515.59-24.23
Net Cash Provided By Used In Investing Activities 63.00-169.0028.0011.0026.00129.0046.8123.45-215.20-268.0618.91-88.613.0062.83-0.23-387.12-87.0740.06-12.1030.3626.6714.282.51-83.34-16.12-16.49-42.0712.73
Net Cash Provided By Used In Financing Activities 2.00229.003.006.0023.001.0011.202.534.3514.9311.671.322.23222.121.68107.52328.870.610.52-0.040.65-0.010.77-0.01-1.12129.43106.600.19

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Operating Activities -94.00-2.00-88.00-63.00-57.00-98.00-69.74-80.96-65.30654.00-62.10-53.76-74.00-66.32-49.88216.26-23.94-31.28-9.47-27.40-19.75-16.84-7.11-11.77-10.88-13.2515.59-24.23
Net Income Loss -93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21-23.12
Profit Loss -93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21NA
Increase Decrease In Accounts Payable 0.00-1.002.006.00-19.0010.008.05-12.163.968.140.65-1.85-11.297.726.11-3.509.01-2.341.820.47-0.05-0.520.96-2.381.65-0.312.04-0.70
Share Based Compensation 20.0020.0018.0018.0018.0019.0016.5216.2615.6816.5413.8114.5913.3712.767.896.004.473.462.442.742.131.671.051.051.120.660.150.14

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Investing Activities 63.00-169.0028.0011.0026.00129.0046.8123.45-215.20-268.0618.91-88.613.0062.83-0.23-387.12-87.0740.06-12.1030.3626.6714.282.51-83.34-16.12-16.49-42.0712.73
Payments To Acquire Property Plant And Equipment 0.004.006.0010.005.003.000.381.321.512.798.517.866.073.641.521.070.260.210.200.550.550.630.261.131.301.050.290.84

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Financing Activities 2.00229.003.006.0023.001.0011.202.534.3514.9311.671.322.23222.121.68107.52328.870.610.52-0.040.65-0.010.77-0.01-1.12129.43106.600.19

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Revenues 39.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Revenue From Contract With Customer Excluding Assessed Tax 39.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Gilead Sciences Inc, Etrumadenant License And Research And Development Services Agreement 3.0024.00NA21.0010.008.00NA3.00NANANANANANANANANANANANANANANANANANANANA
Gilead Sciences Inc, Quemliclustat License And Research And Development Services Agreement 19.00100.006.00-4.007.008.0010.0012.002.002.00NANANANANANANANANANANANANANANANANANA
Gilead Sciences Inc, Research And Development Activities For Domvanalimab 3.007.00NANA1.001.00NANANANANANANANANANANANANANANANANANANANANANA
Gilead Sciences Inc, Research And Development Activities For Inflammation Programs 2.002.001.002.001.00NANANANANANANANANANANANANANANANANANANANANANANA
S T A R221 Development Activities, Taiho Collaboration Agreement NANA14.004.00NANANANANANANANANANANANANANANANANANANANANANANANA
Taiho Pharmaceutical Co Ltd, Option And License Agreement 3.004.001.004.00NANA0.002.001.002.00NANANANANANANANANANANANANANANANANANA
Gilead Collaboration Access Rights 9.008.008.008.009.008.008.008.009.008.00NANANANANANANANANANANANANANANANANANA
Gilead Collaboration License And R D Services 27.00133.0022.0020.0020.0017.0026.0023.0017.008.00NANANANANANANANANANANANANANANANANANA
License And Development Services Revenue 28.00135.0022.0022.0019.0017.0025.6323.7416.697.941.140.000.00NANANANANANANANANANANANANANANA
Other Collaboration Revenue 11.0010.009.0010.0010.008.008.039.8410.0710.079.539.469.469.46NANANANANANANANANANANANANANA
Taiho Collaboration R D Services 3.004.001.004.00NANANANANANANANANANANANANANANANANANANANANANANANA
License And Development Services Revenue, Related Party 25.00131.0021.0018.0019.0017.0026.0023.00NANANANANANANANANANANANANANANANANANANANA
Other Collaboration Revenue, Related Party 11.0010.009.0010.0010.008.008.008.00NANANANANANANANANANANANANANANANANANANANA
Access Rights And Option Continuation Periods 9.008.008.008.009.008.008.008.009.008.00NANANANANANANANANANANANANANANANANANA
Research And Development Activities For Domvanalimab NANA2.001.001.001.002.600.201.300.90NANANANANANANANANANANANANANANANANANA
Research And Development And Commercialization Activities For Zimberelimab NANA0.000.001.00NA0.008.001.00NANANANANANANANANANANANANANANANANANANA
Taiho Collaboration Agreement 3.004.00NANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Property Plant And Equipment Net
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Next Twelve Months

Line plots across dimensions of each concept